Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Monte Rosa Therapeutics, Inc.

GLUE · Nasdaq · CIK 0001826457 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

38 Form 4 transaction lines observed in the same window
21 sales · 17 option, withholding, award, gift or other lines

Last qualifying purchase2025-03-24 · Leo Chandra P. · $58.4K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Champoux JenniferChief Operating Officer
○▼○▼○▼○▼○▼
Janku FilipChief Medical Officer
○▼○▼○▼○▼
Townson SharonChief Scientific Officer
○▼○▼○▼○▼
Manning Anthony M.Director
○▼○▼
Warmuth MarkusPresident & CEO
▼▼▼
Behbahani AliDirector
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-03-24 · Leo Chandra P..

Recent Form 4 activity

0Purchases
37Sales
25Other Form 4 lines
33SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING21 sale line(s) · context only
OTHER17 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
19,686,241
Previous report
19,265,990
Avg daily volume
1,093,381
Days to cover
18.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-03-24Leo Chandra P.Purchase (P)Common Stock10,000USD 5.84USD 58,400SEC filing ↗
2021-06-28Yang RickPurchase (P)Common Stock1,050,000USD 19.00USD 19,950,000SEC filing ↗
2021-06-28Walker Paul EdwardPurchase (P)Common Stock1,050,000USD 19.00USD 19,950,000SEC filing ↗
2021-06-28Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLCPurchase (P)Common Stock157,895USD 19.00USD 3,000,005SEC filing ↗
2021-06-28Sonsini Peter W.Purchase (P)Common Stock1,050,000USD 19.00USD 19,950,000SEC filing ↗
2021-06-28SANDELL SCOTT DPurchase (P)Common Stock1,050,000USD 19.00USD 19,950,000SEC filing ↗
2021-06-28NEA 17 GP, LLC; NEA Partners 17, L.P.; New Enterprise Associates 17, L.P.Purchase (P)Common Stock1,050,000USD 19.00USD 19,950,000SEC filing ↗
2021-06-28Mathers Edward TPurchase (P)Common Stock1,050,000USD 19.00USD 19,950,000SEC filing ↗
2021-06-28Makhzoumi MohamadPurchase (P)Common Stock1,050,000USD 19.00USD 19,950,000SEC filing ↗
2021-06-28MAKOWER JOSHUAPurchase (P)Common Stock1,050,000USD 19.00USD 19,950,000SEC filing ↗
2021-06-28Landsman LizaPurchase (P)Common Stock1,050,000USD 19.00USD 19,950,000SEC filing ↗
2021-06-28Florence Anthony A. Jr.Purchase (P)Common Stock1,050,000USD 19.00USD 19,950,000SEC filing ↗
2021-06-28Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Private Healthcare Fund III LPPurchase (P)Common Stock600,000USD 19.00USD 11,400,000SEC filing ↗
2021-06-28Chang CarmenPurchase (P)Common Stock1,050,000USD 19.00USD 19,950,000SEC filing ↗
2021-06-28Bolzon Bradley J PhDPurchase (P)Common Stock157,895USD 19.00USD 3,000,005SEC filing ↗

Form 4 evidence

62 transaction lines in the latest 365-day window; 145 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-05Bowen MatthewSale (S)Common Stock13USD 10.56USD 137SEC filing ↗
2026-07-16Warmuth MarkusSale (S)Common Stock9,500USD 23.18USD 220,210SEC filing ↗
2026-07-15Champoux JenniferSale (S)Common Stock4,351USD 23.38USD 101,726SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-05Bowen MatthewSale (S)Common Stock13USD 10.56USD 137SEC filing ↗
2026-07-16Warmuth MarkusSale (S)Common Stock9,500USD 23.18USD 220,210SEC filing ↗
2026-07-15Champoux JenniferSale (S)Common Stock4,351USD 23.38USD 101,726SEC filing ↗
2026-07-15Champoux JenniferOption exercise / conversion (M)Common Stock4,351USD 3.98USD 17,317SEC filing ↗
2026-07-06Townson SharonSale (S)Common Stock6,000USD 23.31USD 139,852SEC filing ↗
2026-07-06Townson SharonOption exercise / conversion (M)Common Stock6,000USD 6.14USD 36,840SEC filing ↗
2026-07-01Behbahani AliJ (J)Common Stock1,015,000USD 0.00USD 0SEC filing ↗
2026-06-30Janku FilipSale (S)Common Stock5,407USD 24.50USD 132,472SEC filing ↗
2026-06-30Janku FilipOption exercise / conversion (M)Common Stock5,407USD 13.41USD 72,508SEC filing ↗
2026-06-29Manning Anthony M.Sale (S)Common Stock10,000USD 23.11USD 231,100SEC filing ↗
2026-06-29Manning Anthony M.Option exercise / conversion (M)Common Stock10,000USD 4.16USD 41,600SEC filing ↗
2026-06-29Janku FilipSale (S)Common Stock6,000USD 22.95USD 137,700SEC filing ↗
2026-06-29Janku FilipOption exercise / conversion (M)Common Stock6,000USD 7.56USD 45,360SEC filing ↗
2026-06-24Janku FilipSale (S)Common Stock30,000USD 21.42USD 642,600SEC filing ↗
2026-06-24Janku FilipOption exercise / conversion (M)Common Stock30,000USD 7.56USD 226,800SEC filing ↗
2026-06-23Townson SharonSale (S)Common Stock3,000USD 20.00USD 60,000SEC filing ↗
2026-06-23Townson SharonOption exercise / conversion (M)Common Stock3,000USD 6.14USD 18,420SEC filing ↗
2026-06-23Janku FilipSale (S)Common Stock11,845USD 20.22USD 239,506SEC filing ↗
2026-06-23Janku FilipOption exercise / conversion (M)Common Stock6,000USD 7.56USD 45,360SEC filing ↗
2026-06-23Champoux JenniferSale (S)Common Stock2,175USD 20.00USD 43,500SEC filing ↗
2026-06-23Champoux JenniferOption exercise / conversion (M)Common Stock2,175USD 3.98USD 8,656SEC filing ↗
2026-06-17Townson SharonSale (S)Common Stock3,000USD 19.00USD 57,000SEC filing ↗
2026-06-17Townson SharonOption exercise / conversion (M)Common Stock3,000USD 6.14USD 18,420SEC filing ↗
2026-06-17Champoux JenniferSale (S)Common Stock2,176USD 19.00USD 41,344SEC filing ↗
2026-06-17Champoux JenniferOption exercise / conversion (M)Common Stock2,176USD 3.98USD 8,660SEC filing ↗
2026-06-01Warmuth MarkusSale (S)Common Stock5,466USD 19.44USD 106,245SEC filing ↗
2026-05-29Townson SharonSale (S)Common Stock6,000USD 19.87USD 119,220SEC filing ↗
2026-05-29Townson SharonOption exercise / conversion (M)Common Stock6,000USD 6.14USD 36,840SEC filing ↗
2026-05-27Champoux JenniferSale (S)Common Stock2,175USD 20.00USD 43,500SEC filing ↗
2026-05-27Champoux JenniferOption exercise / conversion (M)Common Stock2,175USD 3.98USD 8,656SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerGLUE
CIK0001826457
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2836 Biological Products, (No Diagnostic Substances)
ExchangeNasdaq

Data coverage

Local Form 4 history145 transaction lines from 2021-06-28 to 2026-10-05
17 P purchase lines · 47 S sale lines · 81 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.